CLDX
Celldex Therapeutics Inc
31.10$
-7.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -171.5% | – | -263.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.0% | +150.0% | +98.9% | -34.1% | +72.2% | -28.1% | -5.9% | +12.4% | +24.1% | -1.6% | +28.2% | -5.6% | +39.2% | +65.9% | -29.0% | -24.6% | -6.1% | +15.5% | +17.9% | +2.0% | +29.8% | -28.4% | +27.8% | -19.1% | -21.9% | -54.4% | +114.9% | +5.6% | -177.9% | |
| – | – | – | – | – | – | – | – | +185.2% | +64.0% | +202.4% | -77.9% | +1,239.4% | -99.9% | -8.4% | -16.4% | -1.9% | +97.9% | +50.7% | +86.4% | +19.9% | -19.6% | -34.4% | -43.7% | -14.0% | +128.7% | +74.4% | +53.0% | +43.3% | +5.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.1% | +104.1% | +51.2% | +86.6% | +20.5% | -98.1% | +30,976.5% | -94.3% | +210.7% | -51.8% | +26.4% | – | – | – | |
| – | – | – | – | +958.5% | -105.9% | – | – | – | +773.9% | +338.8% | -103.1% | – | -97.8% | -4,029.6% | – | +86.7% | +73.7% | -20.2% | +77.7% | -160.3% | – | – | – | – | – | – | – | -260.5% | – | |
| – | -83.3% | +200.0% | +129.5% | -74.3% | +241.5% | -6.2% | -63.0% | -97.1% | -100.0% | – | -46.6% | -73.8% | -59.5% | +297.7% | -75.8% | -40.5% | +1,292.4% | -54.3% | +152.8% | -43.6% | -35.0% | -54.5% | -10.1% | +112.3% | -19.5% | +46.4% | -0.5% | +5.6% | +41.4% | |
| – | – | +406.7% | -57.0% | -129.6% | -19.7% | +8.4% | +162.9% | -25.0% | +31.2% | +328.3% | -38.7% | – | +344.0% | -135.8% | -86.7% | +687.9% | +356.0% | -47.0% | +22.4% | – | -32.6% | -35.8% | -42.7% | -675.0% | +120.1% | – | -217.6% | +174.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -33.1% | – | – | – | – | – | – | – | – | +132.6% | +252.9% | -99.6% | +16,394.5% | -92.5% | +254.2% | -42.6% | -44.8% | +953.2% | +59.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -46.9% | +185.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +169.0% | +321.6% | -66.4% | -100.7% | – | +179.3% | -100.5% | +50.7% | +20.8% | – | -122.6% | – | +162.9% | +180.5% | +263.1% | -99.6% | +16,394.5% | -92.5% | +254.2% | -42.6% | -44.8% | +953.2% | +59.1% | -98.5% | +5,259.6% | +102.1% | -99.5% | |
| – | -2,166.7% | – | +87.3% | +680.9% | -120.5% | – | – | – | -161.7% | – | -244.4% | – | -67.6% | -380.2% | – | – | +1,011.7% | -197.8% | – | -167.2% | – | – | – | – | -114.4% | – | – | -219.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -237.4% | – | -279.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.